INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
98 hedge funds and large institutions have $598M invested in Infinity Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 37 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
57% less call options, than puts
Call options by funds: $4.84M | Put options by funds: $11.2M
Holders
98
Holding in Top 10
1
Calls
$4.84M
Puts
$11.2M
Top Buyers
| 1 | +$6.01M | |
| 2 | +$5.84M | |
| 3 | +$4.59M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$4.37M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$4.22M |
Top Sellers
| 1 | -$15M | |
| 2 | -$9.8M | |
| 3 | -$5.35M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.49M |
| 5 |
Renaissance Technologies
New York
|
-$3.82M |